Pancreatic cancer is notorious for its late diagnosis and poor prognosis. This is largely due to the pancreas being a deep-seated organ, making early detection difficult. Common symptoms such as: ...

A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed tumor growth or activate immune cells against the cancer, according to ...

Pancreatic cancer, particularly pancreatic ductal adenocarcinoma, stands out as one of the most lethal malignancies due to its resistance to conventional treatments and the challenges posed by its ...

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, ...

Researchers identified UBL3 as a regulator that loads PD-L1 into tumor extracellular vesicles, weakening immunotherapy. They ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

Cancer is not a single enemy; it’s a deeply personal battle with unique outcomes for each individual. Discover why ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...

A new study published in the International Journal of Molecular Sciences by researchers from the Georgia Institute of Cannabis Research at Augusta University found that inhaling cannabidiol (CBD) ...

The GINECO window-of-opportunity COLIBRI (NCT04256213) study provides compelling evidence that a neoadjuvant "priming" dose ...